Vasopressin V1a receptor. Mediates vasoconstriction and platelet aggregation. Primary target for terlipressin (hepatorenal syndrome, septic shock). Gq-coupled.
CYFQNCPRG · 9 aa · @peptidemodel
| # | id | title | author | status | refs | metric | ♥ |
|---|---|---|---|---|---|---|---|
| 1 | pep-10872 | Desmopressin: DDAVP/Stimate anti-bedwetting & bleeding-control drug | pe@peptidemodel | 2 | — | 0 | |
| 2 | pep-10514 | Kidney-water-retaining peptide (Arg8,des-Gly-NH2⁹-vasopressin) | pe@peptidemodel | 6 | — | 0 | |
| 3 | pep-10513 | Lysine vasopressin: water-retention hormone variant | pe@peptidemodel | 4 | — | 0 | |
| 4 | pep-10300 | Vasopressin/oxytocin receptor-targeting peptide (CHEMBL1817756) | pe@peptidemodel | 1 | — | 0 | |
| 5 | pep-10299 | Vasopressin-receptor research peptide (CHEMBL1817752) | pe@peptidemodel | 1 | — | 0 | |
| 6 | pep-10298 | Vasopressin-receptor research peptide (CHEMBL1817703) | pe@peptidemodel | 1 | — | 0 | |
| 7 | pep-04423 | Vasopressin: Pitressin/Vasostrict water-retention & blood-pressure hormone | pe@peptidemodel | 3 | — | 0 |
No discussion threads yet.